Collaboration will focus on progressing test for early detection of Alzheimer’s dementia
News
Revvity opens scientific centre of excellence in Cambridge
Facility will deliver technology to scientists, helping them to translate genomic insights
Calliditas reveals pivotal setanaxib data
Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate
Tenpoint receives £10m from British Patient Capital
The company aims to deliver therapies that provide benefits to patients affected by eye diseases
Stada expands its European treatment portfolio
Company adds a number of additional brands from Sanofi following initial take overs in 2021
Sanofi’s Rezurock accepted in Scotland
Therapy treats patients with chronic graft-versus-host disease who have already received other treatments
Patients in UK get early access to GSK’s Jemperli
It concerns the treatment being combined with platinum-containing chemotherapy
Janssen reveals new Spravato data
Period to remission was shortened with esketamine nasal spray in both sub-groups within study
GSK’s Arexvy authorised by MHRA
Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
Novavax COVID-19 vaccine produces immunity
Second dose of treatment generates response among young people during Oxford University trial
Incyte’s Opzelura gets MHRA authorisation
Therapy involves the treatment of non-segmental vitiligo among adults and adolescents
Novartis reveals five-year efficacy data for Kesimpta
Patients treated with Kesimpta experienced considerable decreases in relapse rates
GeneCode receives record Parkinson’s funding
European Innovation Council Accelerator finances treatment development drive for condition
Positive efficacy data for Sensorian’s candidate
SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation
Vertex’s Orkambi receives EC approval
Orkambi is an oral treatment for very young children that combines both lumacaftor and ivacaftor
